Steve Staben

Chief Scientific Officer at Lycia Therapeutics

Speaker

Steve Staben, Ph.D. joined Lycia Therapeutics as Chief Scientific Officer in 2021. Prior to Lycia, he spent approximately 15 years at Genentech leading drug discovery programs in oncology and immunology as well as new modality platforms. His basic research interests include new mechanisms for modulation of therapeutic targets, including applications of induced proximity. Steve holds his Ph.D. in organic chemistry from the University of California, Berkeley.